The founders, Dres. Silvia Pantze, Robin Tremmel, Frieder Helm and Johannes Parmentier from the group of Prof. Fricker, Dept. Pharmaceutical Technology and Biopharmacy, as well as business economist Moritz Stadler develop a technology, which allows oral administration of otherwise parenterally given drugs, e.g. peptides and proteins. These biologicals, covering a market volume of approximately 220 billion US$ p.a. have usually to be given by painful i.v. injections, and therefore alternative routes of administration are most desirable.
Latest Revision: 2017-08-04